Saturday, September 23, 2023
Dr James Burt, Chief Executive Officer at Pharmanovia

Pharmanovia acquires 11 central nervous system brands from Sanofi

Pharmanovia, a pharmaceutical firm that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, announced the expansion of its neurology portfolio with the acquisition of 11 central nervous system (CNS) brands from healthcare company, Sanofi. The brands span four therapy areas of ongoing unmet need associated with CNS disorders - psycholeptic, anxiolytic, anti-epileptic and anti-psychotic.
Sandra Milligan, M.D., J.D., Head of Research and Development at Organon

Organon bolsters its R&D expertise with appointments of Juan Camilo Arjona Ferreira and Charlotte...

Organon, a healthcare company with a focus on women’s health, has appointed Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owens, M.D., as Head of Medical Affairs and Outcomes Research, strengthening its medical capabilities, advancing external relationships and fueling efforts to bring forward innovations to solve unmet health needs. They both report to Sandra Milligan, M.D., J.D., Head of Research and Development.
Ryan Carters

Former professional cricketer Ryan Carters launches new initiative to help boost Australian dads’ mental...

Former professional cricketer Ryan Carters, used this Father’s Day to launch a new support organisation for the dads of Australia and is calling for an urgent boost in Federal Government funding to help support struggling fathers who are battling increased mental health issues. Carters, a father of three, who played for the Sydney Sixers, the Cricket Australia XI, New South Wales and Victoria, said not enough was being done by all levels of Australia's Government to help address systemic issues facing dads and said there needed to be a holistic level of coordinated support networks and programs for fathers. After six months of highly successful community trials, Carters has officially launched the Dadfit program.
Why Australia must address how it tests and diagnoses skin cancer

Australia’s worryingly high skin cancer misdiagnoses: Why we must address how we test and...

Australia is infamous for having the highest skin cancer rates, a gloomy accolade that doesn’t seem to be fading anytime soon. But beneath this widespread knowledge lies a less publicised yet deeply concerning issue: the frequency with which skin cancers are misdiagnosed. When Aussies suspect they might have a skin cancer, the default method by a GP to confirm this is an invasive biopsy, a procedure only registered doctors can perform. But due to the fact that most GPs aren't specialists in the area, many skin cancers are incorrectly diagnosed.

CAS and join hands to help bolster scientific breakthroughs in early-stage drug discovery...

CAS, a division of the American Chemical Society specializing in scientific information solutions, and, a tech-bio specialist in AI-based solutions for pharmaceutical chemistry, have established a strategic collaboration focused on the joint development of computer-aided synthesis design technologies to help accelerate scientific breakthroughs in early-stage drug discovery and aid chemists in the discovery of novel small molecules.
Ryan Klose, Chief Information Officer at Royal Flying Doctor Service

Royal Flying Doctor Service taps Oracle’s technology to launch new nationwide digital health record

The Royal Flying Doctor Service (RFDS), Australia’s rural and remote health services provider, launched a new nationwide Electronic Health Record (EHR) powered by Oracle Autonomous Database, running on Oracle Cloud Infrastructure (OCI), to streamline clinical information collection and analysis leading to faster and better decision-making by medical staff.

Medisca expands its extensive global network of strategic alliances to drive patient access to...

Medisca has announced the expansion of a network of strategic alliances aimed at securing and stabilizing global access to high quality active pharmaceutical ingredients (APIs) for the preparation of essential medications. This mission started with the partnership for Thyroid USP in 2021, and has now expanded to include Progesterone USP (Special Micronized), Testosterone USP (Micronized), Diclofenac Sodium USP, and Ketamine Hydrochloride USP.

Supervised exercise programs can help Aussies struggling with cancer-related fatigue, new research finds

Cancer-related fatigue (CRF), a debilitating condition impacting up to 60% of cancer patients, can be significantly alleviated using supervised exercise programs, according to research published in the Royal Australasian College of Physicians’ (RACP) Internal Medicine Journal. Australia ranks third in the world for incidence of cancer. One in two Australians will develop at least one type of cancer before the age of 85. Due to world-class care, Australians have some of the highest cancer-related survival rates internationally. However, while our health system is saving people’s lives, it is not necessarily helping them thrive post-treatment.
Dr. Yuelei Shen, President and Chief Executive Officer of Biocytogen

Biocytogen’s Project Integrum hits milestone progress, accelerating global antibody business growth

Biocytogen Pharmaceuticals Co., Ltd. announced that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a new stage of rapid growth. Project Integrum is a large-scale research and development (R&D) project that is designed to discover novel therapeutic antibodies for over 1000 druggable targets.
Derek Hei, Scientific Advisory Board member at RoslinCT

RoslinCT announces the appointment of gene therapy expert Dr. Derek Hei to its Scientific...

RoslinCT, a contract development and manufacturing organization (CDMO) for Advanced Cell and Gene therapies, has appointed Derek Hei, Ph.D., to its Scientific Advisory Board (SAB). The SAB is comprised of cell and gene therapy pioneers with experience, providing valuable insight into various topics for the development and manufacturing of advanced therapies.